Lt. Col. Scott Flurry’s Final Mission
A 1,100-Mile Journey Across Borders to Save Lives Through Organ DonationNote: A video accompanying this press release shares Scott's inspiring...
Heart Attack
Esteemed Harvard Medical School Professor Dr. Michael Gibson Appointed Chief Medical Advisor at Lexaria Bioscience
Dr. Gibson joining Lexaria's new scientific advisor board KELOWNA, BC / ACCESSWIRE / December 17, 2024 / Lexaria Bioscience Corp....
Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia
FDA is expected to assign a Prescription Drug User Fee Act (PDUFA) target action date and announce whether Priority Review...
EYLEA HD® (aflibercept) Injection 8 mg Phase 3 Trial Meets Primary Endpoint Showing Improved Vision with Extended Dosing Intervals in Patients with Macular Edema following Retinal Vein Occlusion
EYLEA HD demonstrated non-inferior vision gains with an every 8-week dosing regimen compared to EYLEA® (aflibercept) Injection 2 mg dosed...
HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology
First cable-free, ambulatory ECG that captures the heart’s electrical signals from three distinct directions for high-fidelity data collection and advanced...
Cardio Diagnostics Holdings, Inc. Receives Final Medicare Pricing Determination from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests
CMS pricing determination marks a key milestone in gaining broad access to Medicare reimbursement.CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO),...
Best Legal Steroids: Effective Bodybuilding Steroid Alternatives for Muscle Growth
Closest thing to real steroids to use for cutting and bulking in the bodybuilding industry SAN FRANCISCO, CA / ACCESSWIRE...
Dynocardia has received a $1 million NSF grant to enhance their unique computer vision-based motion-correction technology and expand the applications of its ViTrack® continuous non-invasive blood pressure (cNIBP) monitor
Dynocardia's proprietary computer-vision technology effectively identifies and compensates for movement artifacts. Overcoming these artifacts has long been a significant challenge...
Cytovale Recognized as One of Modern Healthcare’s 2024 Best in Business
Company's IntelliSep® rapid sepsis detection solution recognized for helping hospitals save lives and money while delivering patient-centered care SAN FRANCISCO, Dec....
AliveCor’s Kardia 12L ECG System Awarded Inc.’s 2024 Best in Business Awards
MOUNTAIN VIEW, Calif., Dec. 5, 2024 /PRNewswire/ -- AliveCor, the leading innovator in FDA-cleared personal electrocardiogram (ECG) technology, today announced that...
Avertix Medical to Present at The Benchmark Company’s Upcoming Discovery One-on-One Investor Conference
EATONTOWN, N.J., Dec. 4, 2024 /PRNewswire/ -- Avertix Medical, Inc. ("Avertix" or the "Company"), the developer of The Guardian® system -...
Cleerly Raises $106 Million in Funding Led by Insight Partners to Revolutionize Heart Disease Care
DENVER, Dec. 4, 2024 /PRNewswire/ -- Today Cleerly, a leader in advanced cardiovascular imaging, announced the successful closure of its Series...
Cepham Increases Commitment to Men’s Health With Emphasis on Wellbeing and Plant-Based Ayurvedic Care
SOMERSET, N.J., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Cepham is increasing its commitment to men’s health during the holiday season...
Avricore Health Corporate Update: Effective Plan, Resources Result in Success
VANCOUVER, British Columbia, Nov. 29, 2024 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) reports on its...
AHA 2024: Powerful Medical Makes History as First to Win Both Best Science Startup and Overall Winner Awards
CHICAGO, Nov. 27, 2024 /PRNewswire/ -- Powerful Medical became the first company to win both the Best Science Startup and...
Cleerly Makes Debut at RSNA 2024, Showcasing AI-Enabled Innovations in Cardiovascular Imaging
Join Cleerly Leadership for Live Demonstrations on Advanced Imaging Solutions for Personalized Heart Disease Care DENVER, Nov. 26, 2024 /PRNewswire/...
Revolutionizing Healthcare: Lexaria Highlights Expanding Therapeutic Benefits of GLP-1 Drugs
Semaglutide being investigated for applications in heart disease, Alzheimer's, liver disease, and moreGLP-1 drugs expected to generate multi-hundreds of billions...
Avive Solutions Partners with Academy Safe: Advancing Safety Standards for Martial Arts Studios Across the U.S.
SAN FRANCISCO, Nov. 19, 2024 /PRNewswire/ -- Avive Solutions is proud to announce its partnership with Academy Safe, a non-profit organization...
SEEHER, ABBOTT, AND CVS RELEASE FIRST-EVER HEALTH AND WELLNESS REPORT TO COMBAT HOW WOMEN HAVE BEEN DEPRIORITIZED AND UNDERREPRESENTED IN HEALTHCARE MARKETING
Women are the key decision makers in 80% of all healthcare choices, yet many brands fail to accurately portray them...
Anthos Therapeutics Shares New Analysis from the Landmark AZALEA-TIMI 71 Study Demonstrating the Factor XI Inhibitor Abelacimab Substantially Reduced Bleeding in Patients on Antiplatelet Therapy Compared to Rivaroxaban
Data presented at the American Heart Association Scientific Sessions show a 67% reduction in bleeding for patients on antiplatelet therapy...